a16z Capital Management, L.L.C.
Follow13F filer, CIK 1540358, MENLO PARK, CA
a16z Capital Management, L.L.C. reported $1,579,784,578 across 13 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-17. Its ten largest share positions make up 99.26% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001540358-26-000003
- Period
- 2025-12-31
- Reported value
- $1.58B
- Holdings
- 13
- Top 10 weight
- 99.26%
- New
- 2
- Sold out
- 0
Part of the filer group a16z Capital Management, L.L.C.
How groups are builtLargest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| NAVNnew | +27,195,364 | $464M |
| HTBKnew | +82,740 | $129K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| RVMDreduced | -1,827,424 | -$146M |
| OMDAreduced | -1,153,645 | -$18.2M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q4 2025
Share positions as resolved from 13F-HR 0001540358-26-000003, largest first. % of portfolio is the value over $1,579,784,578, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| FIGFIGMA INC | 16,246,129 | $607M | 38.43% | 0 | Timeline | ||
| NAVNNAVAN INC | 27,195,364 | $464M | 29.4% | new | Timeline | ||
| METAMETA PLATFORMS INC | 212,531 | $140M | 8.88% | 0 | Timeline | ||
| RVMDREVOLUTION MEDICINES INC | 921,099 | $73.4M | 4.64% | -1,827,424 | Timeline | ||
| MAZEMAZE THERAPEUTICS INC | 1,702,225 | $70.5M | 4.46% | 0 | Timeline | ||
| XYZBLOCK INC | 1,016,697 | $66.2M | 4.19% | 0 | Timeline | ||
| OMDAOMADA HEALTH INC | 3,460,929 | $54.6M | 3.46% | -1,153,645 | Timeline | ||
| BIOABIOAGE LABS INC | 3,233,170 | $44.1M | 2.79% | 0 | Timeline | ||
| NAUTNAUTILUS BIOTECHNOLOGY INC | 17,653,917 | $34.4M | 2.18% | 0 | Timeline | ||
| CAMPCAMP4 THERAPEUTICS CORP | 2,125,339 | $13M | 0.82% | 0 | Timeline | ||
| ERASERASCA INC | 2,862,500 | $10.6M | 0.67% | 0 | Timeline | ||
| DNAGINKGO BIOWORKS HOLDINGS INC | 108,568 | $902K | 0.06% | 0 | Timeline | ||
| HTBKHERITAGE COMM CORP | 82,740 | $129K | 0.01% | new | Timeline |
How Q4 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001540358-26-000003 | base | 2026-02-17 | acceptance time not in the bulk data set |